GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jun 17, 2026
GB Sciences Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| 0.1 | - | - | - | - | - | |
Gross Profit | 0.1 | - | - | - | - | - |
Selling, General & Admin | 0.68 | 1.16 | 1.18 | 1.05 | 1.65 | 5.74 |
Research & Development | 0.26 | 0.26 | 0.49 | 0.82 | 0.35 | - |
Operating Expenses | 0.95 | 1.42 | 1.67 | 1.87 | 2 | 5.74 |
Operating Income | -0.85 | -1.42 | -1.67 | -1.87 | -2 | -5.74 |
Interest Expense | -0.19 | -0.22 | -0.18 | -0.47 | -1.29 | -1.11 |
Other Non Operating Income (Expenses) | -0.32 | - | 0.1 | 0.01 | -0.65 | -0.18 |
EBT Excluding Unusual Items | -1.36 | -1.64 | -1.75 | -2.33 | -3.94 | -7.03 |
Gain (Loss) on Sale of Assets | - | - | - | 5.19 | - | 4.39 |
Asset Writedown | -0 | -0.04 | -2.37 | - | - | - |
Other Unusual Items | 0.32 | 0.32 | - | -3 | 0.6 | -2.11 |
Pretax Income | -1.04 | -1.36 | -4.13 | -0.15 | -3.33 | -4.75 |
Earnings From Continuing Operations | -1.04 | -1.36 | -4.13 | -0.15 | -3.33 | -4.75 |
Earnings From Discontinued Operations | - | - | - | -0.38 | -0.39 | -8.36 |
Net Income to Company | -1.04 | -1.36 | -4.13 | -0.53 | -3.73 | -13.11 |
Minority Interest in Earnings | - | - | - | - | - | 0.74 |
Net Income | -1.04 | -1.36 | -4.13 | -0.53 | -3.73 | -12.37 |
Preferred Dividends & Other Adjustments | 0.01 | 0.28 | - | - | - | - |
Net Income to Common | -1.06 | -1.64 | -4.13 | -0.53 | -3.73 | -12.37 |
Shares Outstanding (Basic) | 407 | 397 | 358 | 318 | 285 | 258 |
Shares Outstanding (Diluted) | 407 | 397 | 358 | 318 | 285 | 258 |
Shares Change (YoY) | 4.24% | 10.90% | 12.63% | 11.37% | 10.35% | 23.34% |
EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | -0.05 |
EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | -0.05 |
Free Cash Flow | -0.51 | -0.98 | -1.53 | -1.87 | -2.19 | -4.48 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 |
Gross Margin | 100.00% | - | - | - | - | - |
Operating Margin | -872.53% | - | - | - | - | - |
Profit Margin | -1085.52% | - | - | - | - | - |
Free Cash Flow Margin | -520.84% | - | - | - | - | - |
EBITDA | -0.85 | -1.42 | -1.61 | -1.8 | -1.95 | -5.62 |
D&A For EBITDA | 0 | 0 | 0.06 | 0.07 | 0.05 | 0.13 |
EBIT | -0.85 | -1.42 | -1.67 | -1.87 | -2 | -5.74 |